Shares of La Jolla Pharmaceutical were nosediving on Monday in pre-market trading after Wall Street learned that the company’s president and CEO George Tidmarsh left the company. Tidmarsh, M.D., has left the Company to pursue other interests. A search for a new Chief Executive Officer has been initiated. In the interim, a committee of the … Continue reading “Shares of La Jolla Pharmaceutical Company Crash As CEO Departs”
Biotech & Pharma
Biotech & Pharma
Amarin Shares Explode Ahead of FDA Decision
Shares of Amarin climbed higher on Tuesday ahead of an FDA meeting for the company's…
November 13, 2019
Biotech & Pharma
Agile Therapeutics Shares Explode as Contraceptive Patch Twirla Gets Nod from FDA
Agile Therapeutics shares were on the rise this week, rocketing nearly 300% after the women's…
November 1, 2019
Biotech & Pharma
Biogen Surprises Wall Street With This News
Biogen announced on Tuesday that its Alzheimer's treatment was ready to start the regulatory approval…
October 23, 2019
Biotech & Pharma
Reata Pharmaceuticals Explodes as Company Meets Study Endpoint
Shares of Reata Pharmaceuticals were popping on Monday in after-hours trading as Wall Street learned…
October 15, 2019
Biotech & Pharma
Akcea Therapeutics Soars on Licensing Agreement with Pfizer
Shares of Akcea Therapeutics were exploding on Monday after the company revealed that it had…
October 8, 2019
Biotech & Pharma
Drugstores Are Suspending Sales of Heartburn Medicine Zantac Due to This Health Concern
Walgreens just became the latest retailer to suspend sales of Zantac, a heartburn medicine from…
October 1, 2019
Biotech & Pharma
Tocagen Inc. Falls Over 80% After Late-stage Trial Fails to Meet Endpoint
Shares of Tocagen Inc. were plummeting on Thursday, falling over 80% to a new record…
September 13, 2019
Biotech & Pharma
Sarepta Therapeutics Shares Collapse on Serious Duchenne Gene Therapy Complication
Shares of Sarepta Therapeutics fell as much as 13% on Thursday after Wall Street learned…
August 9, 2019
Biotech & Pharma
Acadia Pharmaceuticals Takes a Nose Dive After Schizophrenia Drug Fails
Acadia Pharmaceuticals Inc. shares were on a decline in after-hours trading on Monday as Wall…
July 22, 2019
Biotech & Pharma
The FDA Has Granted Prevail’s Parkinson’s Treatment Fast Track Designation
Prevail Therapeutics shares were on the rise on Monday after Wall Street learned that the…
July 9, 2019
Biotech & Pharma
Dangerous Side Effects Prompts FDA to Suspend Unum Therapeutics’ Cancer Drug Trial
Shares of Unum Therapeutics were on a downward turn this week after the Food and…
July 5, 2019
Biotech & Pharma
Pfizer to Buy Array BioPharma for $11.4 Billion
Pharmaceutical giant Pfizer revealed this week that it is going to acquire Array BioPharma in…
June 17, 2019
Biotech & Pharma
Merck to Buy Tilos Therapeutics for up to $773 Million
Merck announced this week that it has reached an agreement to buy privately held biopharmaceutical…
June 10, 2019